A novel tumor-targeted delivery system with hydrophobized hyaluronic acid–spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery (Q39547449)

From Wikidata

Jump to navigation Jump to search

scientific article published on April 23, 2011

Language	Label	Description	Also known as
English	A novel tumor-targeted delivery system with hydrophobized hyaluronic acid–spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery	scientific article published on April 23, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

A novel tumor-targeted delivery system with hydrophobized hyaluronic acid–spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery (English)

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

author name string

Yan Shen

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Buhai Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Yang Lu

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Ammar Ouahab

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Qian Li

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Jiasheng Tu

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

language of work or name

0 references

publication date

23 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0378517311003760?httpAccept=text/xml

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

https://api.elsevier.com/content/article/PII:S0378517311003760?httpAccept=text/plain

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

International Journal of Pharmaceutics

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

414

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

233-243

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Hydrophobized dextran-spermine conjugate as potential vector for in vitro gene transfection

1

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Sticky overhangs enhance siRNA-mediated gene silencing

2

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Mechanistic investigation of poly(ethylene imine)-based siRNA delivery: disulfide bonds boost intracellular release of the cargo

3

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Polyhydroxyethylaspartamide-spermine copolymers: efficient vectors for gene delivery

4

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Regulated portals of entry into the cell

5

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Hyaluronic acid as drug delivery for sodium butyrate: improvement of the anti-proliferative activity on a breast-cancer cell line

6

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells

7

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Dextran-spermine-based polyplexes--evaluation of transgene expression and of local and systemic toxicity in mice

8

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Relationships between chemical composition, physical properties and transfection efficiency of polysaccharide-spermine conjugates.

9

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Characterization and in vivo performance of dextran–spermine polyplexes and DOTAP/cholesterol lipoplexes administered locally and systemically

10

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Cyclooxygenase inhibition by diclofenac formulated in bioadhesive carriers

11

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

RNA interference

12

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Cytoplasmic delivery and nuclear targeting of synthetic macromolecules

13

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Heparin-conjugated polyethylenimine for gene delivery.

14

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Chitosan-graft-polyethylenimine for Akt1 siRNA delivery to lung cancer cells

15

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis.

16

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA.

17

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Clathrin-dependent or not: is it still the question?

18

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Establishment and characterization of a SV40 transformed human fetal gastric epithelial cell line-GES-1

19

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation.

20

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery

21

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

PEG conjugated VEGF siRNA for anti-angiogenic gene therapy

22

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Sequence- and target-independent angiogenesis suppression by siRNA via TLR3

23

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

The emergence of clathrin-independent pinocytic pathways.

24

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Intracellular barriers to non-viral gene transfer.

25

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels

26

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells

27

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Uptake and metabolism of novel biodegradable poly (glycerol-adipate) nanoparticles in DAOY monolayer.

28

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Self-crosslinked and reducible fusogenic peptides for intracellular delivery of siRNA.

29

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway

30

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles

31

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Polyplex micelles with cyclic RGD peptide ligands and disulfide cross-links directing to the enhanced transfection via controlled intracellular trafficking

32

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile beta-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells.

33

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells

34

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Positional effect of chemical modifications on short interference RNA activity in mammalian cells

35

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis

36

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle

37

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

39

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells.

40

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery

42

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells.

43

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Targeted delivery of oligodeoxynucleotides to mouse lung endothelial cells in vitro and in vivo

44

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery

45

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in wound healing

46

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Hyaluronic Acid-Modified Bioadhesive Liposomes as Local Drug Depots: Effects of Cellular and Fluid Dynamics on Liposome Retention at Target Sites

47

1 reference

10.1016/J.IJPHARM.2011.04.049

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.04.049

1 December 2024

Identifiers

10.1016/J.IJPHARM.2011.04.049

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39547449&oldid=2282213855"